​At Duke University, Dr. Shah’s research and clinical work focuses on both pediatric and adult sickle cell hematology, with a strong focus on clinical and translational research. Dr. Shah’s research investigates novel therapeutics, the transition from pediatric to adult care, and the usage of mobile technology for those living with sickle cell disease. Dr. Shah’s studies have been led by multiple sponsors including the NIH and various pharmaceutical organizations. Dr. Shah currently sits as the Director of Clinical Research in Benign Hematology at Duke University.